nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNA10—lung—esophageal cancer	0.0209	0.0591	CbGeAlD
Dalfampridine—KCNB1—epithelium—esophageal cancer	0.0183	0.0518	CbGeAlD
Dalfampridine—KCNC3—epithelium—esophageal cancer	0.0177	0.0503	CbGeAlD
Dalfampridine—KCNB1—smooth muscle tissue—esophageal cancer	0.0176	0.0499	CbGeAlD
Dalfampridine—KCNS1—epithelium—esophageal cancer	0.0164	0.0465	CbGeAlD
Dalfampridine—KCNF1—bronchus—esophageal cancer	0.0132	0.0375	CbGeAlD
Dalfampridine—KCNA3—digestive system—esophageal cancer	0.0131	0.0372	CbGeAlD
Dalfampridine—KCNQ1—neck—esophageal cancer	0.0127	0.0361	CbGeAlD
Dalfampridine—KCNA5—bronchus—esophageal cancer	0.0118	0.0336	CbGeAlD
Dalfampridine—KCNS3—epithelium—esophageal cancer	0.0118	0.0334	CbGeAlD
Dalfampridine—KCNS3—bronchus—esophageal cancer	0.0116	0.0329	CbGeAlD
Dalfampridine—KCNA5—smooth muscle tissue—esophageal cancer	0.0116	0.0328	CbGeAlD
Dalfampridine—KCNA3—lung—esophageal cancer	0.011	0.0311	CbGeAlD
Dalfampridine—KCNA5—trachea—esophageal cancer	0.0106	0.0301	CbGeAlD
Dalfampridine—KCNS3—trachea—esophageal cancer	0.0104	0.0295	CbGeAlD
Dalfampridine—KCNC4—lung—esophageal cancer	0.00997	0.0283	CbGeAlD
Dalfampridine—KCND1—lung—esophageal cancer	0.00997	0.0283	CbGeAlD
Dalfampridine—KCNA5—digestive system—esophageal cancer	0.00914	0.0259	CbGeAlD
Dalfampridine—KCNF1—lung—esophageal cancer	0.00853	0.0242	CbGeAlD
Dalfampridine—KCNQ1—bronchus—esophageal cancer	0.00852	0.0242	CbGeAlD
Dalfampridine—KCNA5—lung—esophageal cancer	0.00763	0.0216	CbGeAlD
Dalfampridine—KCNA3—lymph node—esophageal cancer	0.00749	0.0212	CbGeAlD
Dalfampridine—KCNS3—lung—esophageal cancer	0.00747	0.0212	CbGeAlD
Dalfampridine—KCNQ3—lung—esophageal cancer	0.00747	0.0212	CbGeAlD
Dalfampridine—KCNA2—lymph node—esophageal cancer	0.00713	0.0202	CbGeAlD
Dalfampridine—KCNH6—lung—esophageal cancer	0.00682	0.0193	CbGeAlD
Dalfampridine—KCNC4—lymph node—esophageal cancer	0.00682	0.0193	CbGeAlD
Dalfampridine—KCNQ1—digestive system—esophageal cancer	0.00658	0.0187	CbGeAlD
Dalfampridine—KCNQ5—lymph node—esophageal cancer	0.00637	0.0181	CbGeAlD
Dalfampridine—KCND3—lung—esophageal cancer	0.00568	0.0161	CbGeAlD
Dalfampridine—KCNQ1—lung—esophageal cancer	0.0055	0.0156	CbGeAlD
Dalfampridine—KCNA5—lymph node—esophageal cancer	0.00522	0.0148	CbGeAlD
Dalfampridine—KCNS3—lymph node—esophageal cancer	0.00511	0.0145	CbGeAlD
Dalfampridine—KCND3—lymph node—esophageal cancer	0.00388	0.011	CbGeAlD
Dalfampridine—KCNQ1—lymph node—esophageal cancer	0.00376	0.0107	CbGeAlD
Dalfampridine—Balance disorder—Capecitabine—esophageal cancer	0.00254	0.0471	CcSEcCtD
Dalfampridine—Infection—Carboplatin—esophageal cancer	0.00227	0.0422	CcSEcCtD
Dalfampridine—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.00206	0.0381	CcSEcCtD
Dalfampridine—Laryngeal pain—Capecitabine—esophageal cancer	0.00204	0.0377	CcSEcCtD
Dalfampridine—CYP2E1—digestive system—esophageal cancer	0.00193	0.00548	CbGeAlD
Dalfampridine—CYP2E1—lung—esophageal cancer	0.00161	0.00458	CbGeAlD
Dalfampridine—Chest discomfort—Capecitabine—esophageal cancer	0.00157	0.0291	CcSEcCtD
Dalfampridine—KCNH2—lymph node—esophageal cancer	0.00143	0.00407	CbGeAlD
Dalfampridine—Nasopharyngitis—Cisplatin—esophageal cancer	0.00122	0.0227	CcSEcCtD
Dalfampridine—Connective tissue disorder—Cisplatin—esophageal cancer	0.000929	0.0172	CcSEcCtD
Dalfampridine—Nasopharyngitis—Capecitabine—esophageal cancer	0.000901	0.0167	CcSEcCtD
Dalfampridine—KCNQ3—Developmental Biology—PFN1—esophageal cancer	0.000872	0.00147	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PFN1—esophageal cancer	0.000872	0.00147	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SLC52A3—esophageal cancer	0.000862	0.00145	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—BLVRB—esophageal cancer	0.000862	0.00145	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—BLVRB—esophageal cancer	0.000862	0.00145	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—BLVRB—esophageal cancer	0.000862	0.00145	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SLC52A3—esophageal cancer	0.000862	0.00145	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SLC52A3—esophageal cancer	0.000862	0.00145	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—SOX2—esophageal cancer	0.000854	0.00144	CbGpPWpGaD
Dalfampridine—Immune system disorder—Cisplatin—esophageal cancer	0.000854	0.0158	CcSEcCtD
Dalfampridine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000852	0.0158	CcSEcCtD
Dalfampridine—KCNQ2—Axon guidance—ACTB—esophageal cancer	0.000842	0.00142	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—ACTB—esophageal cancer	0.000842	0.00142	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SLC52A3—esophageal cancer	0.000817	0.00138	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—BLVRB—esophageal cancer	0.000817	0.00138	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000813	0.00137	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—NOS2—esophageal cancer	0.000801	0.00135	CbGpPWpGaD
Dalfampridine—Infestation NOS—Capecitabine—esophageal cancer	0.000776	0.0144	CcSEcCtD
Dalfampridine—Infestation—Capecitabine—esophageal cancer	0.000776	0.0144	CcSEcCtD
Dalfampridine—Tremor—Cisplatin—esophageal cancer	0.000771	0.0143	CcSEcCtD
Dalfampridine—Urinary tract infection—Capecitabine—esophageal cancer	0.000754	0.014	CcSEcCtD
Dalfampridine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000747	0.00126	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CA1—esophageal cancer	0.000733	0.00124	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CA1—esophageal cancer	0.000733	0.00124	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SLC10A2—esophageal cancer	0.000733	0.00124	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SLC10A2—esophageal cancer	0.000733	0.00124	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SLC10A2—esophageal cancer	0.000733	0.00124	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CA1—esophageal cancer	0.000733	0.00124	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000714	0.0012	CbGpPWpGaD
Dalfampridine—Convulsion—Cisplatin—esophageal cancer	0.000713	0.0132	CcSEcCtD
Dalfampridine—CYP2E1—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000712	0.0012	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CFL1—esophageal cancer	0.000706	0.00119	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CFL1—esophageal cancer	0.000706	0.00119	CbGpPWpGaD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000705	0.00119	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—NOS2—esophageal cancer	0.0007	0.00118	CbGpPWpGaD
Dalfampridine—Anxiety—Cisplatin—esophageal cancer	0.000698	0.0129	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000696	0.0129	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—SLC10A2—esophageal cancer	0.000695	0.00117	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CA1—esophageal cancer	0.000695	0.00117	CbGpPWpGaD
Dalfampridine—Connective tissue disorder—Capecitabine—esophageal cancer	0.000685	0.0127	CcSEcCtD
Dalfampridine—KCNQ3—Developmental Biology—SOX2—esophageal cancer	0.000682	0.00115	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—SOX2—esophageal cancer	0.000682	0.00115	CbGpPWpGaD
Dalfampridine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000671	0.0125	CcSEcCtD
Dalfampridine—KCNC2—Metabolism—CA2—esophageal cancer	0.00067	0.00113	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CA2—esophageal cancer	0.00067	0.00113	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CA2—esophageal cancer	0.00067	0.00113	CbGpPWpGaD
Dalfampridine—CYP2E1—Tryptophan metabolism—CYP19A1—esophageal cancer	0.00067	0.00113	CbGpPWpGaD
Dalfampridine—Infection—Cisplatin—esophageal cancer	0.000667	0.0124	CcSEcCtD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—SST—esophageal cancer	0.000664	0.00112	CbGpPWpGaD
Dalfampridine—Nervous system disorder—Cisplatin—esophageal cancer	0.000658	0.0122	CcSEcCtD
Dalfampridine—Skin disorder—Cisplatin—esophageal cancer	0.000652	0.0121	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—CA2—esophageal cancer	0.000636	0.00107	CbGpPWpGaD
Dalfampridine—Angiopathy—Capecitabine—esophageal cancer	0.000632	0.0117	CcSEcCtD
Dalfampridine—Immune system disorder—Capecitabine—esophageal cancer	0.000629	0.0117	CcSEcCtD
Dalfampridine—Mediastinal disorder—Capecitabine—esophageal cancer	0.000628	0.0116	CcSEcCtD
Dalfampridine—Hypotension—Cisplatin—esophageal cancer	0.000627	0.0116	CcSEcCtD
Dalfampridine—KCNG2—Metabolism—PLCE1—esophageal cancer	0.000623	0.00105	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ADH7—esophageal cancer	0.000623	0.00105	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ADH7—esophageal cancer	0.000623	0.00105	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PLCE1—esophageal cancer	0.000623	0.00105	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ADH7—esophageal cancer	0.000623	0.00105	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PLCE1—esophageal cancer	0.000623	0.00105	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000616	0.00104	CbGpPWpGaD
Dalfampridine—Mental disorder—Capecitabine—esophageal cancer	0.00061	0.0113	CcSEcCtD
Dalfampridine—Paraesthesia—Cisplatin—esophageal cancer	0.000603	0.0112	CcSEcCtD
Dalfampridine—KCNQ2—Developmental Biology—ACTB—esophageal cancer	0.000601	0.00101	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ACTB—esophageal cancer	0.000601	0.00101	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.0006	0.00101	CbGpPWpGaD
Dalfampridine—Dyspnoea—Cisplatin—esophageal cancer	0.000599	0.0111	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—PLCE1—esophageal cancer	0.000591	0.000996	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ADH7—esophageal cancer	0.000591	0.000996	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CTNNA1—esophageal cancer	0.00059	0.000994	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CTNNA1—esophageal cancer	0.00059	0.000994	CbGpPWpGaD
Dalfampridine—Back pain—Capecitabine—esophageal cancer	0.000587	0.0109	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00058	0.0108	CcSEcCtD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000579	0.000976	CbGpPWpGaD
Dalfampridine—Infestation NOS—Methotrexate—esophageal cancer	0.000578	0.0107	CcSEcCtD
Dalfampridine—Infestation—Methotrexate—esophageal cancer	0.000578	0.0107	CcSEcCtD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000576	0.00097	CbGpPWpGaD
Dalfampridine—Tremor—Capecitabine—esophageal cancer	0.000568	0.0105	CcSEcCtD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000568	0.000957	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—ABL1—esophageal cancer	0.000563	0.000949	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—ABL1—esophageal cancer	0.000563	0.000949	CbGpPWpGaD
Dalfampridine—KCNQ3—L1CAM interactions—EGFR—esophageal cancer	0.00056	0.000944	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—EGFR—esophageal cancer	0.00056	0.000944	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Cisplatin—esophageal cancer	0.000553	0.0103	CcSEcCtD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000549	0.000925	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ADH1B—esophageal cancer	0.000547	0.000921	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ADH1B—esophageal cancer	0.000547	0.000921	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ADH1B—esophageal cancer	0.000547	0.000921	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000541	0.000912	CbGpPWpGaD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000534	0.0009	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—ADH7—esophageal cancer	0.00053	0.000892	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—GNG7—esophageal cancer	0.000524	0.000882	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TYMP—esophageal cancer	0.000522	0.00088	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TYMP—esophageal cancer	0.000522	0.00088	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TYMP—esophageal cancer	0.000522	0.00088	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ADH1B—esophageal cancer	0.000518	0.000873	CbGpPWpGaD
Dalfampridine—Chest pain—Capecitabine—esophageal cancer	0.000516	0.00958	CcSEcCtD
Dalfampridine—Anxiety—Capecitabine—esophageal cancer	0.000515	0.00954	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000513	0.00951	CcSEcCtD
Dalfampridine—KCNC2—Metabolism—CYP26A1—esophageal cancer	0.000508	0.000856	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP26A1—esophageal cancer	0.000508	0.000856	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP26A1—esophageal cancer	0.000508	0.000856	CbGpPWpGaD
Dalfampridine—Confusional state—Capecitabine—esophageal cancer	0.000499	0.00926	CcSEcCtD
Dalfampridine—KCNG2—Metabolism—ALOX15—esophageal cancer	0.000495	0.000834	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TYMP—esophageal cancer	0.000495	0.000834	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ALOX15—esophageal cancer	0.000495	0.000834	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ALOX15—esophageal cancer	0.000495	0.000834	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Cisplatin—esophageal cancer	0.000495	0.00917	CcSEcCtD
Dalfampridine—Infection—Capecitabine—esophageal cancer	0.000492	0.00912	CcSEcCtD
Dalfampridine—KCNH2—Neuronal System—ALDH2—esophageal cancer	0.000491	0.000827	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—EP300—esophageal cancer	0.00049	0.000825	CbGpPWpGaD
Dalfampridine—Nervous system disorder—Capecitabine—esophageal cancer	0.000485	0.009	CcSEcCtD
Dalfampridine—Asthenia—Cisplatin—esophageal cancer	0.000482	0.00893	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—CYP26A1—esophageal cancer	0.000482	0.000812	CbGpPWpGaD
Dalfampridine—Skin disorder—Capecitabine—esophageal cancer	0.000481	0.00892	CcSEcCtD
Dalfampridine—KCNC2—Metabolism—TPI1—esophageal cancer	0.000472	0.000796	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TPI1—esophageal cancer	0.000472	0.000796	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTO1—esophageal cancer	0.000472	0.000796	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TPI1—esophageal cancer	0.000472	0.000796	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTO1—esophageal cancer	0.000472	0.000796	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTO1—esophageal cancer	0.000472	0.000796	CbGpPWpGaD
Dalfampridine—Angiopathy—Methotrexate—esophageal cancer	0.000471	0.00873	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—ALOX15—esophageal cancer	0.000469	0.000791	CbGpPWpGaD
Dalfampridine—Immune system disorder—Methotrexate—esophageal cancer	0.000468	0.00869	CcSEcCtD
Dalfampridine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000467	0.00867	CcSEcCtD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000467	0.000787	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—ADH1B—esophageal cancer	0.000464	0.000782	CbGpPWpGaD
Dalfampridine—Hypotension—Capecitabine—esophageal cancer	0.000463	0.00858	CcSEcCtD
Dalfampridine—Mental disorder—Methotrexate—esophageal cancer	0.000454	0.00843	CcSEcCtD
Dalfampridine—KCNC2—Metabolism—ALDOB—esophageal cancer	0.000453	0.000763	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ALDOB—esophageal cancer	0.000453	0.000763	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ALDOB—esophageal cancer	0.000453	0.000763	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTO1—esophageal cancer	0.000448	0.000755	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TPI1—esophageal cancer	0.000448	0.000755	CbGpPWpGaD
Dalfampridine—Insomnia—Capecitabine—esophageal cancer	0.000448	0.0083	CcSEcCtD
Dalfampridine—Paraesthesia—Capecitabine—esophageal cancer	0.000444	0.00824	CcSEcCtD
Dalfampridine—Dyspnoea—Capecitabine—esophageal cancer	0.000441	0.00818	CcSEcCtD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000439	0.00074	CbGpPWpGaD
Dalfampridine—Back pain—Methotrexate—esophageal cancer	0.000437	0.0081	CcSEcCtD
Dalfampridine—KCNC2—Metabolism—GAPDH—esophageal cancer	0.000436	0.000735	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GAPDH—esophageal cancer	0.000436	0.000735	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GAPDH—esophageal cancer	0.000436	0.000735	CbGpPWpGaD
Dalfampridine—Dyspepsia—Capecitabine—esophageal cancer	0.000436	0.00808	CcSEcCtD
Dalfampridine—KCNG2—Metabolism—CRABP1—esophageal cancer	0.000432	0.000728	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CRABP1—esophageal cancer	0.000432	0.000728	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CRABP1—esophageal cancer	0.000432	0.000728	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP26A1—esophageal cancer	0.000432	0.000727	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALDOB—esophageal cancer	0.000429	0.000723	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—EP300—esophageal cancer	0.000428	0.000721	CbGpPWpGaD
Dalfampridine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000427	0.00792	CcSEcCtD
Dalfampridine—KCNQ2—Axon guidance—KDR—esophageal cancer	0.000427	0.00072	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KDR—esophageal cancer	0.000427	0.00072	CbGpPWpGaD
Dalfampridine—Vomiting—Cisplatin—esophageal cancer	0.000427	0.00792	CcSEcCtD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000426	0.000717	CbGpPWpGaD
Dalfampridine—Rash—Cisplatin—esophageal cancer	0.000423	0.00785	CcSEcCtD
Dalfampridine—Constipation—Capecitabine—esophageal cancer	0.000423	0.00785	CcSEcCtD
Dalfampridine—Dermatitis—Cisplatin—esophageal cancer	0.000423	0.00784	CcSEcCtD
Dalfampridine—KCNQ2—Axon guidance—MET—esophageal cancer	0.000418	0.000704	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MET—esophageal cancer	0.000418	0.000704	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GAPDH—esophageal cancer	0.000413	0.000696	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GNG7—esophageal cancer	0.000411	0.000693	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GNG7—esophageal cancer	0.000411	0.000693	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GNG7—esophageal cancer	0.000411	0.000693	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CRABP1—esophageal cancer	0.00041	0.00069	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Capecitabine—esophageal cancer	0.000408	0.00756	CcSEcCtD
Dalfampridine—KCNQ3—Developmental Biology—ABL1—esophageal cancer	0.000402	0.000677	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ABL1—esophageal cancer	0.000402	0.000677	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTO1—esophageal cancer	0.000401	0.000676	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.000399	0.000672	CbGpPWpGaD
Dalfampridine—Nausea—Cisplatin—esophageal cancer	0.000399	0.0074	CcSEcCtD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTO1—esophageal cancer	0.000396	0.000667	CbGpPWpGaD
Dalfampridine—Urticaria—Capecitabine—esophageal cancer	0.000393	0.00729	CcSEcCtD
Dalfampridine—Convulsion—Methotrexate—esophageal cancer	0.000391	0.00725	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—GNG7—esophageal cancer	0.00039	0.000656	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—SMAD4—esophageal cancer	0.000389	0.000656	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—SMAD4—esophageal cancer	0.000389	0.000656	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ALDH2—esophageal cancer	0.000385	0.000649	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ALDH2—esophageal cancer	0.000385	0.000649	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ALDH2—esophageal cancer	0.000385	0.000649	CbGpPWpGaD
Dalfampridine—Chest pain—Methotrexate—esophageal cancer	0.000384	0.00713	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000382	0.00708	CcSEcCtD
Dalfampridine—Confusional state—Methotrexate—esophageal cancer	0.000372	0.00689	CcSEcCtD
Dalfampridine—Anaphylactic shock—Methotrexate—esophageal cancer	0.000368	0.00683	CcSEcCtD
Dalfampridine—KCNS3—Metabolism—GSTT1—esophageal cancer	0.000366	0.000617	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTT1—esophageal cancer	0.000366	0.000617	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTT1—esophageal cancer	0.000366	0.000617	CbGpPWpGaD
Dalfampridine—Infection—Methotrexate—esophageal cancer	0.000366	0.00679	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—ALDH2—esophageal cancer	0.000365	0.000615	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Capecitabine—esophageal cancer	0.000365	0.00676	CcSEcCtD
Dalfampridine—KCNG2—Metabolism—CYP2A6—esophageal cancer	0.000362	0.00061	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP2A6—esophageal cancer	0.000362	0.00061	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP2A6—esophageal cancer	0.000362	0.00061	CbGpPWpGaD
Dalfampridine—Nervous system disorder—Methotrexate—esophageal cancer	0.000361	0.0067	CcSEcCtD
Dalfampridine—Skin disorder—Methotrexate—esophageal cancer	0.000358	0.00664	CcSEcCtD
Dalfampridine—Asthenia—Capecitabine—esophageal cancer	0.000355	0.00659	CcSEcCtD
Dalfampridine—KCND2—Circadian rythm related genes—TP53—esophageal cancer	0.00035	0.00059	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTT1—esophageal cancer	0.000347	0.000585	CbGpPWpGaD
Dalfampridine—Hypotension—Methotrexate—esophageal cancer	0.000344	0.00638	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—CYP2A6—esophageal cancer	0.000343	0.000578	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS1—esophageal cancer	0.000343	0.000578	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ENO1—esophageal cancer	0.000343	0.000578	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ENO1—esophageal cancer	0.000343	0.000578	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS1—esophageal cancer	0.000343	0.000578	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ENO1—esophageal cancer	0.000343	0.000578	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS1—esophageal cancer	0.000343	0.000578	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PSME2—esophageal cancer	0.000338	0.00057	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PSME2—esophageal cancer	0.000338	0.00057	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PSME1—esophageal cancer	0.000338	0.00057	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PSME1—esophageal cancer	0.000338	0.00057	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PSME2—esophageal cancer	0.000338	0.00057	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PSME1—esophageal cancer	0.000338	0.00057	CbGpPWpGaD
Dalfampridine—Insomnia—Methotrexate—esophageal cancer	0.000333	0.00618	CcSEcCtD
Dalfampridine—Paraesthesia—Methotrexate—esophageal cancer	0.000331	0.00614	CcSEcCtD
Dalfampridine—Dyspnoea—Methotrexate—esophageal cancer	0.000328	0.00609	CcSEcCtD
Dalfampridine—Dizziness—Capecitabine—esophageal cancer	0.000327	0.00607	CcSEcCtD
Dalfampridine—CYP2E1—Biological oxidations—ALDH2—esophageal cancer	0.000327	0.000551	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000326	0.000549	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS1—esophageal cancer	0.000325	0.000548	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ENO1—esophageal cancer	0.000325	0.000548	CbGpPWpGaD
Dalfampridine—Dyspepsia—Methotrexate—esophageal cancer	0.000324	0.00601	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—PSME1—esophageal cancer	0.000321	0.00054	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PSME2—esophageal cancer	0.000321	0.00054	CbGpPWpGaD
Dalfampridine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000318	0.0059	CcSEcCtD
Dalfampridine—Vomiting—Capecitabine—esophageal cancer	0.000315	0.00584	CcSEcCtD
Dalfampridine—Rash—Capecitabine—esophageal cancer	0.000312	0.00579	CcSEcCtD
Dalfampridine—Dermatitis—Capecitabine—esophageal cancer	0.000312	0.00578	CcSEcCtD
Dalfampridine—CYP2E1—Biological oxidations—GSTT1—esophageal cancer	0.000311	0.000524	CbGpPWpGaD
Dalfampridine—Headache—Capecitabine—esophageal cancer	0.00031	0.00575	CcSEcCtD
Dalfampridine—CYP2E1—Biological oxidations—CYP2A6—esophageal cancer	0.000308	0.000518	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—esophageal cancer	0.000306	0.000516	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—ERBB2—esophageal cancer	0.000305	0.000515	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—ERBB2—esophageal cancer	0.000305	0.000515	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KDR—esophageal cancer	0.000305	0.000513	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KDR—esophageal cancer	0.000305	0.000513	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Methotrexate—esophageal cancer	0.000304	0.00563	CcSEcCtD
Dalfampridine—KCNQ3—Developmental Biology—MET—esophageal cancer	0.000298	0.000502	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MET—esophageal cancer	0.000298	0.000502	CbGpPWpGaD
Dalfampridine—Nausea—Capecitabine—esophageal cancer	0.000294	0.00545	CcSEcCtD
Dalfampridine—Urticaria—Methotrexate—esophageal cancer	0.000293	0.00543	CcSEcCtD
Dalfampridine—KCNS3—Metabolism—CYP1B1—esophageal cancer	0.000292	0.000492	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP1B1—esophageal cancer	0.000292	0.000492	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP1B1—esophageal cancer	0.000292	0.000492	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—PTGS1—esophageal cancer	0.000292	0.000491	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NOTCH1—esophageal cancer	0.000287	0.000484	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NOTCH1—esophageal cancer	0.000287	0.000484	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP1B1—esophageal cancer	0.000277	0.000466	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP19A1—esophageal cancer	0.000274	0.000462	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP19A1—esophageal cancer	0.000274	0.000462	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP19A1—esophageal cancer	0.000274	0.000462	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Methotrexate—esophageal cancer	0.000271	0.00503	CcSEcCtD
Dalfampridine—Asthenia—Methotrexate—esophageal cancer	0.000264	0.0049	CcSEcCtD
Dalfampridine—KCNQ2—Developmental Biology—CREBBP—esophageal cancer	0.00026	0.000439	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CREBBP—esophageal cancer	0.00026	0.000439	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP19A1—esophageal cancer	0.00026	0.000438	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HMOX1—esophageal cancer	0.00025	0.000422	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—HMOX1—esophageal cancer	0.00025	0.000422	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HMOX1—esophageal cancer	0.00025	0.000422	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP1B1—esophageal cancer	0.000248	0.000418	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000245	0.000412	CbGpPWpGaD
Dalfampridine—Dizziness—Methotrexate—esophageal cancer	0.000244	0.00452	CcSEcCtD
Dalfampridine—KCNS3—Metabolism—ABCB1—esophageal cancer	0.00024	0.000405	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ABCB1—esophageal cancer	0.00024	0.000405	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ABCB1—esophageal cancer	0.00024	0.000405	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—HMOX1—esophageal cancer	0.000237	0.0004	CbGpPWpGaD
Dalfampridine—Vomiting—Methotrexate—esophageal cancer	0.000234	0.00434	CcSEcCtD
Dalfampridine—CYP2E1—Biological oxidations—CYP19A1—esophageal cancer	0.000233	0.000393	CbGpPWpGaD
Dalfampridine—Rash—Methotrexate—esophageal cancer	0.000232	0.00431	CcSEcCtD
Dalfampridine—Dermatitis—Methotrexate—esophageal cancer	0.000232	0.0043	CcSEcCtD
Dalfampridine—Headache—Methotrexate—esophageal cancer	0.000231	0.00428	CcSEcCtD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00023	0.000387	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ABCB1—esophageal cancer	0.000228	0.000384	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000222	0.000374	CbGpPWpGaD
Dalfampridine—Nausea—Methotrexate—esophageal cancer	0.000219	0.00406	CcSEcCtD
Dalfampridine—KCNQ3—Developmental Biology—ERBB2—esophageal cancer	0.000218	0.000367	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ERBB2—esophageal cancer	0.000218	0.000367	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—EGFR—esophageal cancer	0.000212	0.000357	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—EGFR—esophageal cancer	0.000212	0.000357	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EP300—esophageal cancer	0.000177	0.000299	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EP300—esophageal cancer	0.000177	0.000299	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CREBBP—esophageal cancer	0.000161	0.000271	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CREBBP—esophageal cancer	0.000161	0.000271	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CREBBP—esophageal cancer	0.000161	0.000271	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CREBBP—esophageal cancer	0.000152	0.000257	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EGFR—esophageal cancer	0.000151	0.000255	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EGFR—esophageal cancer	0.000151	0.000255	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NOS3—esophageal cancer	0.000144	0.000242	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NOS3—esophageal cancer	0.000144	0.000242	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NOS3—esophageal cancer	0.000144	0.000242	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NOS3—esophageal cancer	0.000136	0.00023	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS2—esophageal cancer	0.000132	0.000222	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS2—esophageal cancer	0.000132	0.000222	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS2—esophageal cancer	0.000132	0.000222	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—BLVRB—esophageal cancer	0.000125	0.000211	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC52A3—esophageal cancer	0.000125	0.000211	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS2—esophageal cancer	0.000125	0.00021	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—EP300—esophageal cancer	0.000109	0.000184	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—EP300—esophageal cancer	0.000109	0.000184	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—EP300—esophageal cancer	0.000109	0.000184	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC10A2—esophageal cancer	0.000107	0.000179	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CA1—esophageal cancer	0.000107	0.000179	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—EP300—esophageal cancer	0.000104	0.000175	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CA2—esophageal cancer	9.74e-05	0.000164	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PLCE1—esophageal cancer	9.06e-05	0.000153	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ADH7—esophageal cancer	9.06e-05	0.000153	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CA—esophageal cancer	8.09e-05	0.000136	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CA—esophageal cancer	8.09e-05	0.000136	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CA—esophageal cancer	8.09e-05	0.000136	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ADH1B—esophageal cancer	7.94e-05	0.000134	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CA—esophageal cancer	7.67e-05	0.000129	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TYMP—esophageal cancer	7.59e-05	0.000128	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP26A1—esophageal cancer	7.38e-05	0.000124	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALOX15—esophageal cancer	7.19e-05	0.000121	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTO1—esophageal cancer	6.86e-05	0.000116	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TPI1—esophageal cancer	6.86e-05	0.000116	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALDOB—esophageal cancer	6.58e-05	0.000111	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GAPDH—esophageal cancer	6.33e-05	0.000107	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CRABP1—esophageal cancer	6.28e-05	0.000106	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GNG7—esophageal cancer	5.97e-05	0.000101	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALDH2—esophageal cancer	5.59e-05	9.43e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTT1—esophageal cancer	5.32e-05	8.97e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP2A6—esophageal cancer	5.26e-05	8.86e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ENO1—esophageal cancer	4.99e-05	8.4e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS1—esophageal cancer	4.99e-05	8.4e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PSME2—esophageal cancer	4.91e-05	8.28e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PSME1—esophageal cancer	4.91e-05	8.28e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP1B1—esophageal cancer	4.24e-05	7.15e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP19A1—esophageal cancer	3.99e-05	6.72e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HMOX1—esophageal cancer	3.64e-05	6.13e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCB1—esophageal cancer	3.49e-05	5.88e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CREBBP—esophageal cancer	2.33e-05	3.93e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NOS3—esophageal cancer	2.09e-05	3.52e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS2—esophageal cancer	1.91e-05	3.22e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—EP300—esophageal cancer	1.59e-05	2.68e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CA—esophageal cancer	1.18e-05	1.98e-05	CbGpPWpGaD
